companydata.dkcompanydata.dk

TAK Biopharma IVS: Financial statements 2018

CVR: 37962872

Source: annual report 2018, Danish Business Authority

01/01/2018 – 31/12/2018

TAK Biopharma IVS (CVR 37962872) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 205,532 and a net result of DKK 149,224 compared with DKK -23,344 the year before. That is an increase of 155.9% compared with the year before. The profit margin was 72.6%. Equity in the 2018 report amounted to DKK -37,530.

Revenue
DKK 205,532
Gross Profit
DKK 149,232
Profit/Loss
DKK 149,224
Equity
DKK -37,530
Total Assets
DKK 16,399

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2018206K149K149K-38K-
201780K67K-23K-187K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

TAK Biopharma IVS: The 2017 annual report is outJun 20, 2018

TAK Biopharma IVS has published its annual report for 2017. Revenue came to DKK 80,322, and the net result was DKK -23,344.

About TAK Biopharma IVS

TAK Biopharma IVS was a Danish company of the type Iværksætterselskab based in København N, founded in 2016. The company has been dissolved on 20 June 2021. The company was registered under the industry Fremstilling af farmaceutiske råvarer. The company has 1 employee (2020). In 2019, the company reported revenue of DKK 379,951 and a net result of DKK -22,190 compared with DKK 149,224 the year before. Equity in the 2019 report amounted to DKK -59,720.

Source: annual report 2019, Danish Business Authority

Other financial years